By Ahmed Aboulenein WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to ...

Halo Pharma becomes a standalone drug product CDMO after the sale of Noramco’s API assets, adding sterile services by H2 2026 ...

SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland) -- The transaction is subject to customary closing ...

HANGZHOU CITY, ZHEJIANG, CHINA, January 19, 2026 /EINPresswire.com/ -- With the development of the pharmaceutical and ...

Meanwhile, a total of 76 innovative medical devices, of which 80 percent were domestically developed, were granted market ...

Collaboration between development, quality, and purchasing departments is crucial for a secure supply chain, reducing risks and ensuring compliance. The Parenteral Drug Association's revised standard ...

Amid the surging wave of innovation in China's biopharmaceutical industry, a decade is long enough to witness the full evolution of a sector-from its initial emergence and growth to fundamental ...

HANGZHOU CITY, ZHEJIANG PROVINCE, CHINA, January 20, 2026 /EINPresswire.com/ -- The global fine chemicals industry is ...

JINYE ROAD NO.32, HIGH-TECH ZONE, XI'AN, SHAANXI PROVINCE, CHINA, January 16, 2026 /EINPresswire.com/ -- The global ...

Tropical disease drug discovery is an interdisciplinary field at the intersection of medicinal chemistry, computational biology, and global health. Despite ...

Ultragenyx Resubmits Biologics License Application for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA) ...

BioDlink, a leading global contract development and manufacturing organization (CDMO), has released a white paper titled ...